Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 44, 2010, Pages 19002-19007

  Rivera, Johanna ^a   Cordero, Radames J B ^a   Nakouzi, Antonio S ^a   Frases, Susana ^b   Nicola, André ^a,c   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

^c UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Immunizations; Monoclonal antibody; Passive immunity

Indexed keywords

ANTHROLYSIN; BACTERIAL TOXIN; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; BACILLUS ANTHRACIS; BACTERIAL CELL; BACTERIAL STRAIN; BAGG ALBINO MOUSE; BIOLOGICAL WARFARE; CELL MEMBRANE; CELL VACUOLE; CONFERENCE PAPER; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM POSITIVE BACTERIUM; HOST CELL; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; IMMUNOGENICITY; LETHAL GENE; MACROPHAGE; MEMBRANE VESICLE; MOUSE; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; SUPERNATANT;

BACILLUS (BACTERIUM); BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); MUS; POSIBACTERIA;

EID: 78650507281     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1008843107     Document Type: Article

References (47)

1. Inglesby TV, et al.; Working Group on Civilian Biodefense (1999) Anthrax as a biological weapon: Medical and public health management. JAMA 281:1735-1745.
2. Inglesby TV, et al.; Working Group on Civilian Biodefense (2002) Anthrax as a biological weapon, 2002: Updated recommendations for management. JAMA 287: 2236-2252.
3. Mock M, Fouet A (2001) Anthrax. Annu Rev Microbiol 55:647-671.
4. Collier RJ, Young JA (2003) Anthrax toxin. Annu Rev Cell Dev Biol 19:45-70.
5. Mock M, Mignot T (2003) Anthrax toxins and the host: A story of intimacy. Cell Microbiol 5(1):15-23.
6. Kintzer AF, et al. (2010) Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma. J Mol Biol 399:741-758.
7. Kintzer AF, et al. (2009) The protective antigen component of anthrax toxin forms functional octameric complexes. J Mol Biol 392:614-629.
8. Leppla SH (1982) Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci USA 79: 3162-3166.
9. Leppla SH (1984) Bacillus anthracis calmodulin-dependent adenylate cyclase: Chemicaland enzymatic properties and interactions with eucaryotic cells. Adv Cyclic Nucleotide Protein Phosphorylation Res 17:189-198.
10. Ellis TN, Kuehn MJ (2010) Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev 74(1):81-94.
11. Kuehn MJ, Kesty NC (2005) Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev 19:2645-2655.
12. Rodrigues ML, et al. (2008) Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot Cell 7(1):58-67.
13. Rodrigues ML, et al. (2007) Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. EukaryotCell 6(1):48-59.
14. Kadurugamuwa JL, Beveridge TJ (1995) Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: A novel mechanism of enzyme secretion. J Bacteriol 177: 3998-4008.
15. Kadurugamuwa JL, Beveridge TJ (1996) Bacteriolytic effect of membrane vesicles fromPseudomonas aeruginosa on other bacteria including pathogens: Conceptually new antibiotics. J Bacteriol 178:2767-2774.
16. Kadurugamuwa JL, Beveridge TJ (1999) Membrane vesicles derived from Pseudomonas aeruginosa and Shigella flexneri can be integrated into the surfaces of other Gram-negative bacteria. Microbiology 145:2051-2060.
17. Bauman SJ, Kuehn MJ (2009) Pseudomonas aeruginosa vesicles associate with and are internalized by human lung epithelial cells. BMC Microbiol 9:26.
18. Dorward DW, Garon CF (1990) DNA is packaged within membrane-derived vesicles of Gram-negative but not Gram-positive bacteria. Appl Environ Microbiol 56:1960-1962.
19. Marsollier L, et al. (2007) Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. PLoS Pathog 3(5):e62.
20. Lee EY, et al. (2009) Gram-positive bacteria produce membrane vesicles: Proteomicsbased characterization of Staphylococcus aureus-derived membrane vesicles. Proteomics 9:5425-5436.
21. Kim SH, et al. (2009) Structural modifications of outer membrane vesicles to refinethem as vaccine delivery vehicles. Biochim Biophys Acta 1788:2150-2159.
22. Rivera J, et al. (2009) Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthrax. Antimicrob Agents Chemother 53:4860-4868.
23. Casadevall A, Nosanchuk JD, Williamson P, Rodrigues ML (2009) Vesicular transport across the fungal cell wall. Trends Microbiol 17(4):158-162.
24. Egelhaaf SU, Wehrli E, Muller M, AdrianM, Schurtenberger P (1996) Determination of the size distribution of lecithin liposomes: A comparative study using freeze fracture, cryoelectron microscopy, and dynamic light scattering. J Microsc 184:214-228.
25. Abboud N, et al. (2009) Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies. J Biol Chem 284:25077-25086.
26. Rivera J, et al. (2006) A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1. Infect Immun 74:4149-4156.
27. Winterroth L, Rivera J, Nakouzi AS, Dadachova E, Casadevall A (2010) Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax. Infect Immun 78:2890-2898.
28. Kesty NC, Kuehn MJ (2004) Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles. J Biol Chem 279: 2069-2076.
29. Kesty NC, Mason KM, Reedy M, Miller SE, Kuehn MJ (2004) Enterotoxigenic Escherichiacoli vesicles target toxin delivery into mammalian cells. EMBO J 23: 4538-4549.
30. Bauman SJ, Kuehn MJ (2006) Purification of outer membrane vesicles from Pseudomonasaeruginosa and their activation of an IL-8 response. Microbes Infect 8:2400-2408.
31. Fiocca R, et al. (1999) Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of releasedtoxin and vesicles by gastric epithelium. J Pathol 188:220-226.
32. Beveridge TJ (1999) Structures of Gram-negative cell walls and their derived membrane vesicles. J Bacteriol 181:4725-4733.
33. Dorward DW, Garon CF, Judd RC (1989) Export and intercellular transfer of DNA via membrane blebs of Neisseria gonorrhoeae. J Bacteriol 171:2499-2505.
34. Kolling GL, Matthews KR (1999) Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl Environ Microbiol 65:1843-1848.
35. Kadurugamuwa JL, Beveridge TJ (1998) Delivery of the non-membrane- permeative antibiotic gentamicin into mammalian cells by using Shigella flexneri membrane vesicles. Antimicrob Agents Chemother 42:1476-1483.
36. Li Z, Clarke AJ, Beveridge TJ (1998) Gram-negative bacteria produce membrane vesicles which are capable of killing other bacteria. J Bacteriol 180:5478-5483.
37. Eisenman HC, Frases S, Nicola AM, Rodrigues ML, Casadevall A (2009) Vesicleassociated melanization in Cryptococcus neoformans. Microbiology 155:3860-3867.
38. Nakouzi A, Rivera J, Rest RF, Casadevall A (2008) Passive administration of monoclonal antibodies to anthrolysin O prolong survival in mice lethally infected with Bacillus anthracis. BMC Microbiol 8:159.
39. Mosser EM, Rest RF (2006) The Bacillus anthracis cholesterol-dependent cytolysin, Anthrolysin O, kills human neutrophils, monocytes and macrophages. BMC Microbiol 6:56.
40. Edelson BT, Unanue ER (2001) Intracellular antibody neutralizes Listeria growth. Immunity 14:503-512.
41. LambertMA, Moss CW(1976) Cellular fatty acid composition of Streptococcus mutans and related streptococci. J Dent Res 55:A96-A102.
42. Nair MK, et al. (2005) Antibacterial effect of caprylic acid and monocaprylin on major bacterial mastitis pathogens. J Dairy Sci 88:3488-3495.
43. Sado-Kamdem SL, Vannini L, Guerzoni ME (2009) Effect of alpha-linolenic, capric andlauric acid on the fatty acid biosynthesis in Staphylococcus aureus. Int J Food Microbiol129:288-294.
44. Fonseca FL, et al. (2010) Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter. Infect Immun 78:3861-3870.
45. Frases S, Nimrichter L, Viana NB, Nakouzi A, Casadevall A (2008) Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot Cell 7:319-327.
46. Casadevall A, Mukherjee J, Scharff MD (1992) Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J Immunol Methods 154(1):27-35.
47. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.